Quotient Bioresearch

Pharmaron acquires Quotient Bioresearch

Friday, February 5, 2016

Pharmaron, a fully integrated CRO offering laboratory and manufacturing services for pharmaceutical and biotech research and development, has acquired Quotient Bioresearch. Quotient, a U.K.-based CRO with more than 200 employees, focuses on integrating radiochemistry and metabolism. Part of this expertise is derived from Quotient’s previous acquisition of GE Amersham’s radiosynthesis business.

[Read More]